Stay updated on Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial
Sign up to get notified when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.

Latest updates to the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page
- Check6 days agoChange DetectedThe page now shows a newer revision tag, v3.5.4. The previous tag, v3.5.3, has been removed, signaling a minor metadata update to the page.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision metadata updated from v3.5.2 to v3.5.3, indicating a new version of the page. This is a maintenance/version update that does not alter the study details or content.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a new revision note 'Revision: v3.5.2' and removed the previous revision note 'Revision: v3.5.0'.SummaryDifference0.0%

- Check63 days agoChange DetectedThe MeSH term 'Inflammatory breast carcinoma' was added. A new resources entry for the Genetic and Rare Diseases Information Center was added, and the page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check70 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check92 days agoChange DetectedNo significant additions or deletions were detected; the page content and layout appear unchanged.SummaryDifference0.0%

Stay in the know with updates to Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ipilimumab+Nivolumab for Stage IV IBC Clinical Trial page.